Welcome to our dedicated page for Macerich SEC filings (Ticker: MAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Macerich Company SEC filings document the reporting, governance and capital-structure matters of a retail real estate investment trust listed on the New York Stock Exchange under the symbol MAC. Form 8-K reports furnish earnings results and supplemental financial and operating information, including financial highlights, capital information, changes in common and equivalent shares or units, and portfolio-related operating data.
Other filings cover Regulation FD business update presentations, annual meeting proxy materials, board and stockholder voting matters, and material agreements involving the company and its operating partnership, The Macerich Partnership, L.P. The filing record also includes disclosures on revolving credit facilities, direct financial obligations, completed property sales, exhibit filings, and the company’s common stock registration and exchange listing.
The Macerich Company reported the results of its annual meeting of stockholders held on June 1, 2026. Stockholders elected eight directors to serve until the next annual meeting, with each nominee receiving over 214 million votes in favor.
Stockholders approved the compensation of the company’s named executive officers, with 211,705,512 votes for, 17,257,788 against and 104,018 abstentions, and 11,123,711 broker non-votes. They also ratified the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 237,981,568 votes for, 2,023,584 against and 185,877 abstentions.
HERNANDEZ ENRIQUE JR reported acquisition or exercise transactions in this Form 4 filing.
MACERICH CO director Enrique Hernandez Jr reported a compensation-related stock award. He received 6,720 shares of Common Stock as a grant of restricted stock units at a price of $0.0000 per share under The Macerich Company 2003 Equity Incentive Plan.
The award is non-cash compensation and the restricted stock units vest one year after the award date. The filing notes 1,818 previously unreported restricted stock units credited as dividend equivalents under the plan’s deferral feature. Following the grant, Hernandez directly holds 71,444 shares and indirectly holds 18,416 shares through a living trust.
Stephen Andrea M reported acquisition or exercise transactions in this Form 4 filing.
Macerich Company director Andrea M. Stephen received a non-cash equity award of 6,720 shares of Common Stock in the form of restricted stock units under The Macerich Company 2003 Equity Incentive Plan. These restricted stock units vest one year after the award date.
After this grant and the inclusion of 3,413 previously unreported restricted stock units credited as dividend equivalents under the plan’s deferral feature, Stephen’s direct holdings total 104,921 shares of Common Stock.
LAING DIANA reported acquisition or exercise transactions in this Form 4 filing.
Macerich director Diana Laing received a non-cash grant of 6,720 restricted stock units under The Macerich Company 2003 Equity Incentive Plan. These units vest one year after the award date. Following the grant and including 625 dividend-equivalent units, she holds 163,291 common shares/units directly.
Lowenthal Marianne reported acquisition or exercise transactions in this Form 4 filing.
Macerich Company director Marianne Lowenthal received a grant of 6,720 shares of Common Stock as non-cash compensation. The award was in the form of restricted stock units under The Macerich Company 2003 Equity Incentive Plan and carries a zero dollar grant price. The restricted stock units vest one year after the award date of 2026-06-01. Following this grant, Lowenthal directly holds 43,596 shares of Macerich common stock.
Murphy Devin Ignatius reported acquisition or exercise transactions in this Form 4 filing.
MACERICH CO director Devin Ignatius Murphy reported a stock-based compensation grant rather than a market purchase. He received 6,720 shares of common stock in the form of restricted stock units under The Macerich Company 2003 Equity Incentive Plan, at no cash cost, which vest one year after the award date. Following this grant, he holds 24,621 shares of common stock directly, including 414 previously unreported restricted stock units credited as dividend equivalents under the plan’s deferral feature.
Hirsch Daniel J. reported acquisition or exercise transactions in this Form 4 filing.
MACERICH CO director Daniel J. Hirsch received a non-cash award of 6,720 restricted stock units of Common Stock under The Macerich Company 2003 Equity Incentive Plan. These units vest one year after the award date. Following the award, he directly holds 91,898 shares and indirectly holds 4,732 shares through a family trust.
Hash Steve reported acquisition or exercise transactions in this Form 4 filing.
MACERICH CO director Steve Hash received a grant of 9,520 shares of Common Stock as restricted stock units, awarded as non-cash compensation under The Macerich Company 2003 Equity Incentive Plan.
The restricted stock units vest one year after the award date. Following this grant and prior credited units, Hash now holds 156,153 shares directly, including 4,876 restricted stock units credited as dividend equivalents under the plan’s deferral feature.
The Macerich Company filed an 8-K to furnish a new investor presentation updating its Path Forward Plan and long-term outlook. The deck highlights a Class A–focused mall portfolio, progress on deleveraging, and a substantial leasing and redevelopment pipeline intended to support future growth.
The Go-Forward Portfolio generated sales of $941 per square foot and averages seven annual visits per center, with roughly 90% of NOI coming from Class A properties. Management reports record leasing in 2025, an in-place Signed Not Open pipeline of about $120 million of incremental annual revenue and a goal of roughly $140 million. Pro forma leverage has been reduced by 1.5x from 8.76x at year-end 2023 to 7.76x net debt to EBITDA as of March 31, 2026, with a stated target of about 6.0x.
The presentation outlines illustrative 2028 Pro Forma NOI for the Go-Forward Portfolio in a range of $950–$990 million and a 2028 target FFO per share between $1.80 and $2.00, based on approximately 300 million shares. Macerich also notes about $1.3 billion of completed asset sales, a further $300–$400 million of anticipated 2026 dispositions, and a $900 million revolving credit facility contributing to roughly $1.2 billion of available liquidity.
The Macerich Company completed a common stock offering, issuing and selling 22,080,000 shares at a public offering price of $21.00 per share under an underwriting agreement with Goldman Sachs & Co. LLC and other underwriters. The underwriters’ 30-day option to purchase up to an additional 2,880,000 shares of common stock was exercised in full.
The company will contribute the net proceeds to The Macerich Partnership, L.P. in exchange for securities with economic interests similar to the common stock. The operating partnership intends to use the net proceeds to repay borrowings under the company’s revolving credit facility, which were used primarily to fund the acquisition of Annapolis Mall, and for general corporate purposes including acquiring additional properties and funding strategic leasing capital investments at Annapolis Mall, with any interim funds held in short-term, interest-bearing deposits.